IL-33 mediates the expressions of IL-5 and IL-13 in Angiostrongylus cantonensis-infected mice
Authors:
- Feng-Kuan LinFLFeng-Kuan Lin
- Chih-Cheng ChuangCCChih-Cheng Chuang
- 1 November 2013
- journal article
- Published by Elsevier in Experimental Parasitology
- Vol. 135 (3) , 587-594
Abstract
No abstract availableKeywords
Funding Information
- Shin Kong Wu Ho-Su Memorial Hospital (SKH-FJU-96-1)
This publication has 37 references indexed in Scilit:
- Interleukin 33 Mediates Type 2 Immunity and Inflammation in the Central Nervous System of Mice Infected With Angiostrongylus cantonensisThe Journal of Infectious Diseases, 2012
- Interleukin-33: a novel mediator with a role in distinct disease pathologiesJournal of Internal Medicine, 2010
- IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent InflammationPLOS ONE, 2010
- Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthmaBiochemical and Biophysical Research Communications, 2009
- Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2–IL-33 PathwayAmerican Journal of Respiratory and Critical Care Medicine, 2009
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Secretory IgA induces antigen-independent eosinophil survival and cytokine production without inducing effector functionsJournal of Allergy and Clinical Immunology, 2005
- Eosinophils function as antigen-presenting cellsJournal of Leukocyte Biology, 2004
- Combined Treatment with Interleukin-12 and Mebendazole Lessens the Severity of Experimental Eosinophilic Meningitis Caused byAngiostrongylus cantonensisin ICR MiceInfection and Immunity, 2003
- Do Eosinophils have a Role in the Killing of Helminth Parasites?Parasitology Today, 2000